The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
Kavanagh, K.L., Guo, K., Dunford, J.E., Wu, X., Knapp, S., Ebetino, F.H., Rogers, M.J., Russell, R.G., Oppermann, U.(2006) Proc.Natl.Acad.Sci.USA 103: 7829-7834
- PubMed: 16684881 
- DOI: 10.1073/pnas.0601643103
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Osteoporosis and low bone mass are currently estimated to be a major public health risk affecting >50% of the female population over the age of 50. Because of their bone-selective pharmacokinetics, nitrogen-containing bisphosphonates (N-BPs), current ...